-
Periodontopathogens Redirect Ang I to Ang-(1–7)
2026-08-27
This study shows that Porphyromonas gingivalis and Tannerella forsythia can redirect angiotensin I processing toward Angiotensin (1-7) through surface-associated PepO metalloproteases. By combining enzymology, structural biology, immunoassays, bacterial genetics, and a Galleria mellonella infection model, the authors identify a microbial route for local renin–angiotensin system modulation while also defining important species-specific limits on virulence and physiological interpretation.
-
FTO–FOXO1 m6A Control of ADSC Osteogenesis
2026-08-27
Wang et al. identify an FTO–FOXO1–RUNX2/PPARG pathway that connects m6A RNA modification with osteogenic differentiation in adipose-derived stem cells. The study combines genetic, molecular, and in vivo evidence, while also showing why pharmacological FTO inhibition may compromise ADSC-based bone regeneration.
-
One-step TUNEL Cy3 Apoptosis Detection Kit Guide
2026-08-26
Apply the One-step TUNEL Cy3 Apoptosis Detection Kit to map DNA fragmentation in liver injury models, tissue sections, and cultured cells. This workflow-focused guide combines practical controls, Cy3 imaging strategy, assay optimization, and troubleshooting for more defensible apoptosis measurements.
-
N-Formimidoyl Thienamycin vs β-Lactams
2026-08-26
The 1982 study systematically compared N-formimidoyl thienamycin with several emerging β-lactam antibiotics in resistant Enterobacteriaceae, Pseudomonas, Acinetobacter, enterococci, and oxacillin-resistant staphylococci. Its main contribution was to connect broad in vitro potency with bactericidal behavior and apparent independence from β-lactamase production, while also identifying important organism-specific differences.
-
Bay 11-7085: Translational NF-κB Strategy
2026-08-25
Bay 11-7085 offers translational researchers a practical way to interrogate NF-κB-dependent inflammation, proliferation, and apoptosis. This thought-leadership guide connects its mechanism to endometriosis, pneumococcal meningitis, and ER stress-related neuroinflammation after subarachnoid hemorrhage while emphasizing controls, model maturity, and the limits of chemical-probe evidence.
-
MG-132: From Proteostasis to Translational Insight
2026-08-25
A mechanistic and strategic guide to using MG-132 (Z-LLL-al) to connect proteasome inhibition with apoptosis, cell-cycle control, oxidative stress, and translational research decisions.
-
Tropifexor (LJN452): A Translational FXR Playbook
2026-08-24
Tropifexor (LJN452) offers a precise way to interrogate FXR biology across intestinal barrier, metabolic, and liver disease models. This thought-leadership guide connects receptor pharmacology with experimental design, translational decision-making, and evidence-based pathway attribution.
-
Deferasirox Fe3+ Chelate: Assay Design Guide
2026-08-24
Deferasirox Fe3+ chelate supports iron overload treatment research with a key experimental distinction: a preformed ferric complex is not automatically equivalent to free deferasirox. This guide connects iron chelation mechanism, assay selection, speciation, and reproducible handling for beta-thalassemia and chronic anemia research.
-
A Multimodal iPSC Platform for Cystic Fibrosis Drugs
2026-08-23
Berical and colleagues developed patient-derived iPSC airway models representing common and rare CFTR dysfunction and adapted complementary functional assays for drug testing. The platform links genotype to baseline channel activity and modulator response, offering a route to investigate CFTR variants that are difficult to study with conventional models.
-
Deferasirox, ROS, and NF-κB in Myeloid Maturation
2026-08-22
Jeffries and colleagues show that deferasirox affects myeloid maturation in a stage-dependent manner, linking mitochondrial ROS, NF-κB-related transcription, and reduced terminal neutrophil maturation. The work clarifies why an oral iron chelator can produce distinct effects in progenitors and mature neutrophils while highlighting oxygen tension as an important experimental variable.
-
Hematoxylin and Eosin Staining Kit Guide
2026-08-22
The Hematoxylin and Eosin Staining Kit provides ready-to-use reagents for consistent nuclear and cytoplasmic contrast in paraffin sections, frozen sections, and cytological preparations. It is intended for research-based tissue morphology visualization and cellular structure assessment, not clinical diagnosis or medical use.
-
Cepharanthine: From Mechanism to Translation
2026-08-21
Cepharanthine, a biscoclaurine alkaloid, is emerging as a versatile translational research tool linking mitochondrial apoptosis, DNA-damage signaling, immunomodulation, and disease modeling. This thought-leadership analysis examines recent endometriosis evidence, cancer applications, experimental design, competitive positioning, and the practical steps needed to move from cell assays to patient-derived organoids and in vivo validation.
-
MDockPeP2_VS for Peptide Inhibitor Discovery
2026-08-20
The 2024 PNAS Nexus study introduces MDockPeP2_VS, an automated structure-based method that narrows peptide conformational searches by combining molecular docking with structural conservation between protein folding and protein–peptide binding. Applied to TEM-1 β-lactamase, the workflow identified TF7 as a micromolar inhibitor, illustrating how computational peptide screening can support β-lactam antibiotic resistance research.
-
EPI-001: A Domain-Aware AR Assay Strategy
2026-08-20
EPI-001, an androgen receptor N-terminal domain inhibitor, offers a way to distinguish ligand-binding-domain escape from broader AR transcriptional control. This article translates prostate and triple-negative breast cancer evidence into a practical, mechanism-led assay strategy.
-
circEIF2S2 Drives Colorectal Cancer Progression
2026-08-19
The reference study identifies an EIF4A3–circEIF2S2–miR-646–UHMK1 regulatory axis that connects circular RNA biogenesis with colorectal cancer growth, metastasis, and immune suppression. Its combined molecular, cellular, co-culture, and xenograft evidence positions circEIF2S2 as a mechanistically testable candidate for CRC biology, while also highlighting the need for further validation in clinically representative models.